[The antithrombophilic complex of the arterial wall in the therapy of obliterating arteriopathies in lower limbs (author's transl)]. 1980

M Catalano, and G Carzaniga, and G Fiore, and L Lunardi, and A Libretti

For 30 patients affected by obliterating arteriopathy in lower limbs, the use was made of an antithrombophilic complex of the arterial wall (aorta) consisting of both anti-coagulating and fybrinolytic principles. The results obtained, as regards both subjective and objective symptomatology, clearly showed a considerable increase in the hematic flow in the limbs affected by arteriopathy. Also the flow of the collateral circulation was improved. At the same time, a meaningful reduction in the abnormal cholesterol values was found. The preparation showed no antigenic activity. As or the oral administration, this preparation proved to be an effective one. Tolerance was completely satisfactory.

UI MeSH Term Description Entries
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003097 Collateral Circulation Maintenance of blood flow to an organ despite obstruction of a principal vessel. Blood flow is maintained through small vessels. Blood Circulation, Collateral,Circulation, Collateral,Collateral Blood Circulation,Collateral Circulation, Blood,Blood Collateral Circulation,Circulation, Blood Collateral,Circulation, Collateral Blood,Collateral Blood Circulations,Collateral Circulations,Collateral Circulations, Blood
D005260 Female Females
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Catalano, and G Carzaniga, and G Fiore, and L Lunardi, and A Libretti
January 1977, Bollettino della Societa italiana di cardiologia,
M Catalano, and G Carzaniga, and G Fiore, and L Lunardi, and A Libretti
June 1980, Minerva medica,
M Catalano, and G Carzaniga, and G Fiore, and L Lunardi, and A Libretti
January 1977, Journal belge de medecine physique = Belgisch tijdschrift voor fysische geneeskunde,
M Catalano, and G Carzaniga, and G Fiore, and L Lunardi, and A Libretti
January 1977, Journal belge de medecine physique = Belgisch tijdschrift voor fysische geneeskunde,
M Catalano, and G Carzaniga, and G Fiore, and L Lunardi, and A Libretti
May 1980, Minerva cardioangiologica,
M Catalano, and G Carzaniga, and G Fiore, and L Lunardi, and A Libretti
October 1971, Minerva cardioangiologica,
M Catalano, and G Carzaniga, and G Fiore, and L Lunardi, and A Libretti
June 1982, Minerva cardioangiologica,
M Catalano, and G Carzaniga, and G Fiore, and L Lunardi, and A Libretti
September 1987, La Clinica terapeutica,
M Catalano, and G Carzaniga, and G Fiore, and L Lunardi, and A Libretti
June 1968, Angiology,
M Catalano, and G Carzaniga, and G Fiore, and L Lunardi, and A Libretti
March 1974, Minerva medica,
Copied contents to your clipboard!